VALLEY NATIONAL ADVISERS INC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 15 filers reported holding CLOVIS ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VALLEY NATIONAL ADVISERS INC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2022$2,000
-33.3%
1,5050.0%0.00%
-100.0%
Q2 2022$3,0000.0%1,5050.0%0.00%0.0%
Q1 2022$3,000
-25.0%
1,5050.0%0.00%0.0%
Q4 2021$4,000
-42.9%
1,5050.0%0.00%0.0%
Q3 2021$7,000
+133.3%
1,505
+198.0%
0.00%0.0%
Q2 2021$3,000
-25.0%
5050.0%0.00%0.0%
Q1 2021$4,000
+100.0%
5050.0%0.00%
Q4 2020$2,000
-33.3%
5050.0%0.00%
-100.0%
Q3 2020$3,0000.0%5050.0%0.00%0.0%
Q2 2020$3,0000.0%5050.0%0.00%0.0%
Q1 2020$3,000
-40.0%
5050.0%0.00%0.0%
Q4 2019$5,000
+150.0%
5050.0%0.00%0.0%
Q3 2019$2,0005050.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 814,833$45,630,648,00043.63%
EcoR1 Capital, LLC 384,348$21,523,00010.89%
Palo Alto Investors LP 2,102,857$117,760,0006.91%
NEA Management Company, LLC 2,279,781$127,668,0006.19%
Redmile Group, LLC 721,632$40,411,0004.40%
Opaleye Management Inc. 140,000$7,840,0003.96%
CLIFTON PARK CAPITAL MANAGEMENT, LLC 790,555$44,271,0002.63%
SUFFOLK CAPITAL MANAGEMENT LLC 339,327$19,002,0002.31%
PFM Health Sciences, LP 1,725,126$96,607,0002.26%
HARBOURVEST PARTNERS LLC 51,037$2,858,0001.50%
View complete list of CLOVIS ONCOLOGY INC shareholders